People · Operator
Named in public records as an officer, director or promoter · active 2013–2025 · Pharma, Biotechnology, Other Technology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Alessa Therapeutics, Inc. | — | Pharma | Series B | $31.6M | $129.5M | 2025 |
| Epiodyne, Inc. | — | Biotechnology | Series A | $14.3M | $289.2M | 2016 |
| Mitokinin, Inc. | — | Biotechnology | Series A | $9.5M | $180.8M | 2018 |
| Invenio Imaging, Inc. | — | Other Technology | Seed | $7.5M | $78.8M | 2018 |
| Tangible Science, Inc. (fka Tangible Science, LLC) | — | Biotechnology | Seed | $4.3M | $59.9M | 2016 |
| Photoswitch Biosciences, Inc. | — | Biotechnology | Pre-Seed | $1.5M | $27.6M | 2017 |
| Delpor, Inc. | — | Pharmaceuticals | Pre-Seed | $1.4M | $22.2M | 2013 |
| Zephyrus Biosciences, Inc. | — | Biotechnology | Pre-Seed | $300K | $16.6M | 2014 |
Douglas Crawford at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Douglas Crawford on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Parker | 3 | 6 |
| Doug Crawford | 3 | 3 |
| Jay Trautman | 2 | 2 |
| Richard Lim | 1 | 14 |
| Brook Byers | 1 | 13 |
| Ernest Mario | 1 | 9 |
| Cam Gallagher | 1 | 7 |
| Zachary Collins | 1 | 3 |
| Hanson Gifford | 1 | 3 |
| John Maroney | 1 | 3 |
| Elaine Heron | 1 | 3 |
| Johannes Fruehauf | 1 | 2 |
| Nicholas Hertz | 1 | 2 |
| Annie Mitsak | 1 | 2 |
| Steve Tregay | 1 | 2 |
| Richard Popp | 1 | 2 |
| Alex Tkachenko | 1 | 2 |
| Brian Shoichet | 1 | 2 |
| DANIEL ORRINGER | 1 | 1 |
| Victor McCray | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.